- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain A- Water bridges: A:N.154
NAG-NAG.9: 4 residues within 4Å:- Chain B: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain B- Water bridges: B:N.154
NAG-NAG.16: 4 residues within 4Å:- Chain C: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain C- Water bridges: C:N.154
NAG-NAG.23: 4 residues within 4Å:- Chain D: D.2, F.3, N.5, N.154
1 PLIP interactions:1 interactions with chain D- Water bridges: D:N.154
- 4 x 9SM: (2R,3R,4R,5R,6S)-5-acetamido-6-[(2S)-2,3-bis(oxidanyl)propyl]-2,3-bis(fluoranyl)-4-oxidanyl-oxane-2-carboxylic acid(Non-covalent)
9SM.3: 9 residues within 4Å:- Chain A: S.286, A.288, S.289, S.291, N.318, T.319, D.320, W.321, K.352
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:W.321, A:W.321
- Hydrogen bonds: A:S.286, A:S.289, A:S.291, A:S.291, A:N.318, A:N.318, A:K.352
9SM.10: 9 residues within 4Å:- Chain B: S.286, A.288, S.289, S.291, N.318, T.319, D.320, W.321, K.352
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:W.321, B:W.321
- Hydrogen bonds: B:S.286, B:S.289, B:S.291, B:S.291, B:N.318, B:N.318, B:K.352
9SM.17: 9 residues within 4Å:- Chain C: S.286, A.288, S.289, S.291, N.318, T.319, D.320, W.321, K.352
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:W.321, C:W.321
- Hydrogen bonds: C:S.286, C:S.289, C:S.291, C:S.291, C:N.318, C:N.318, C:K.352
9SM.24: 9 residues within 4Å:- Chain D: S.286, A.288, S.289, S.291, N.318, T.319, D.320, W.321, K.352
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:W.321, D:W.321
- Hydrogen bonds: D:S.286, D:S.289, D:S.291, D:S.291, D:N.318, D:N.318, D:K.352
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Chain A: N.65, W.357
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.65, A:W.357
NAG.11: 2 residues within 4Å:- Chain B: N.65, W.357
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.65, B:W.357
NAG.18: 2 residues within 4Å:- Chain C: N.65, W.357
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:N.65, C:W.357
NAG.25: 2 residues within 4Å:- Chain D: N.65, W.357
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:N.65, D:W.357
- 4 x CA: CALCIUM ION(Non-covalent)
CA.5: 5 residues within 4Å:- Chain A: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:D.213, A:G.217, A:D.244, H2O.1, H2O.4
CA.12: 5 residues within 4Å:- Chain B: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:D.213, B:G.217, B:D.244, H2O.17, H2O.21
CA.19: 5 residues within 4Å:- Chain C: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:D.213, C:G.217, C:D.244, H2O.34, H2O.37
CA.26: 5 residues within 4Å:- Chain D: D.213, G.217, D.244, N.266, G.267
5 PLIP interactions:3 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:D.213, D:G.217, D:D.244, H2O.50, H2O.53
- 4 x 9S4: (2~{S},3~{R},4~{R},5~{R})-3-acetamido-2-[(2~{S})-2,3-bis(oxidanyl)propyl]-5-fluoranyl-4-oxidanyl-2,3,4,5-tetrahydropyran-1-ium-6-carboxylic acid(Non-covalent)
9S4.6: 14 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, R.290, Y.324
- Ligands: 9SJ.7
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:W.98, A:I.142
- Hydrogen bonds: A:R.71, A:R.144, A:E.197, A:R.212, A:R.212
- Water bridges: A:R.37, A:E.147, A:E.147, A:E.147, A:E.197
- Salt bridges: A:R.37, A:R.212, A:R.290
- Halogen bonds: A:D.70
9S4.13: 14 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, R.290, Y.324
- Ligands: 9SJ.14
16 PLIP interactions:16 interactions with chain B- Hydrophobic interactions: B:W.98, B:I.142
- Hydrogen bonds: B:R.71, B:R.144, B:E.197, B:R.212, B:R.212
- Water bridges: B:R.37, B:E.147, B:E.147, B:E.147, B:E.197
- Salt bridges: B:R.37, B:R.212, B:R.290
- Halogen bonds: B:D.70
9S4.20: 14 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, R.290, Y.324
- Ligands: 9SJ.21
16 PLIP interactions:16 interactions with chain C- Hydrophobic interactions: C:W.98, C:I.142
- Hydrogen bonds: C:R.71, C:R.144, C:E.197, C:R.212, C:R.212
- Water bridges: C:R.37, C:E.147, C:E.147, C:E.147, C:E.197
- Salt bridges: C:R.37, C:R.212, C:R.290
- Halogen bonds: C:D.70
9S4.27: 14 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, R.290, Y.324
- Ligands: 9SJ.28
16 PLIP interactions:16 interactions with chain D- Hydrophobic interactions: D:W.98, D:I.142
- Hydrogen bonds: D:R.71, D:R.144, D:E.197, D:R.212, D:R.212
- Water bridges: D:R.37, D:E.147, D:E.147, D:E.147, D:E.197
- Salt bridges: D:R.37, D:R.212, D:R.290
- Halogen bonds: D:D.70
- 4 x 9SJ: 5-acetamido-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid(Post Translational Modification)
9SJ.7: 15 residues within 4Å:- Chain A: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
- Ligands: 9S4.6
17 PLIP interactions:17 interactions with chain A- Hydrophobic interactions: A:W.98, A:I.142, A:R.144
- Hydrogen bonds: A:R.71, A:R.144, A:E.197, A:R.212, A:R.212
- Water bridges: A:R.75, A:R.144, A:E.147, A:E.147, A:E.197
- Salt bridges: A:R.37, A:R.212, A:R.290
- Halogen bonds: A:D.70
9SJ.14: 15 residues within 4Å:- Chain B: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
- Ligands: 9S4.13
17 PLIP interactions:17 interactions with chain B- Hydrophobic interactions: B:W.98, B:I.142, B:R.144
- Hydrogen bonds: B:R.71, B:R.144, B:E.197, B:R.212, B:R.212
- Water bridges: B:R.75, B:R.144, B:E.147, B:E.147, B:E.197
- Salt bridges: B:R.37, B:R.212, B:R.290
- Halogen bonds: B:D.70
9SJ.21: 15 residues within 4Å:- Chain C: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
- Ligands: 9S4.20
17 PLIP interactions:17 interactions with chain C- Hydrophobic interactions: C:W.98, C:I.142, C:R.144
- Hydrogen bonds: C:R.71, C:R.144, C:E.197, C:R.212, C:R.212
- Water bridges: C:R.75, C:R.144, C:E.147, C:E.147, C:E.197
- Salt bridges: C:R.37, C:R.212, C:R.290
- Halogen bonds: C:D.70
9SJ.28: 15 residues within 4Å:- Chain D: R.37, E.38, D.70, R.71, W.98, I.142, R.144, A.166, E.196, E.197, R.212, N.214, R.290, Y.324
- Ligands: 9S4.27
17 PLIP interactions:17 interactions with chain D- Hydrophobic interactions: D:W.98, D:I.142, D:R.144
- Hydrogen bonds: D:R.71, D:R.144, D:E.197, D:R.212, D:R.212
- Water bridges: D:R.75, D:R.144, D:E.147, D:E.147, D:E.197
- Salt bridges: D:R.37, D:R.212, D:R.290
- Halogen bonds: D:D.70
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McKimm-Breschkin, J.L. et al., Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives. J. Med. Chem. (2018)
- Release Date
- 2018-02-21
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x 9SM: (2R,3R,4R,5R,6S)-5-acetamido-6-[(2S)-2,3-bis(oxidanyl)propyl]-2,3-bis(fluoranyl)-4-oxidanyl-oxane-2-carboxylic acid(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x 9S4: (2~{S},3~{R},4~{R},5~{R})-3-acetamido-2-[(2~{S})-2,3-bis(oxidanyl)propyl]-5-fluoranyl-4-oxidanyl-2,3,4,5-tetrahydropyran-1-ium-6-carboxylic acid(Non-covalent)
- 4 x 9SJ: 5-acetamido-2,6-anhydro-3,5,7-trideoxy-3-fluoro-D-threo-L-galacto-nononic acid(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- McKimm-Breschkin, J.L. et al., Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives. J. Med. Chem. (2018)
- Release Date
- 2018-02-21
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A